CBIO
Nuveen Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,059,121
| Closed | -$3.19M | – | 3358 |
|
|
2021
Q1 | $3.19M | Buy |
1,059,121
+668,527
| +171% | +$2.01M | ﹤0.01% | 2391 |
|
|
2020
Q4 | $1.47M | Buy |
390,594
+48,245
| +14% | +$181K | ﹤0.01% | 2659 |
|
|
2020
Q3 | $1.05M | Buy |
342,349
+189,600
| +124% | +$582K | ﹤0.01% | 2666 |
|
|
2020
Q2 | $575K | Buy |
152,749
+20,026
| +15% | +$75.4K | ﹤0.01% | 2845 |
|
|
2020
Q1 | $302K | Sell |
132,723
-1,228
| -0.9% | -$2.79K | ﹤0.01% | 2920 |
|
|
2019
Q4 | $709K | Hold |
133,951
| – | – | ﹤0.01% | 2807 |
|
|
2019
Q3 | $577K | Sell |
133,951
-7,840
| -6% | -$33.8K | ﹤0.01% | 2894 |
|
|
2019
Q2 | $1.69M | Buy |
+141,791
| New | +$1.69M | ﹤0.01% | 2510 |
|